Leukemia relapse after transplantation - a consensus on monitoring, prevention, and treatment in China.
作者信息
Zhan Huichun
机构信息
Division of Hematology and Oncology, Department of Medicine, Stony Brook School of Medicine, Stony Brook University, Stony Brook, NY, 11794, USA.
Northport VA Medical Center, Northport, New York, USA.
出版信息
BMC Med. 2019 Feb 12;17(1):34. doi: 10.1186/s12916-019-1273-1.
Abstract
摘要
相似文献
1
Leukemia relapse after transplantation - a consensus on monitoring, prevention, and treatment in China.移植后白血病复发——中国关于监测、预防及治疗的共识
BMC Med. 2019 Feb 12;17(1):34. doi: 10.1186/s12916-019-1273-1.
2
Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.异基因造血干细胞移植后巨细胞病毒再激活与移植后存活至第100天的急性髓系白血病患者复发风险降低相关：日本造血细胞移植学会移植相关并发症工作组
Biol Blood Marrow Transplant. 2015 Nov;21(11):2008-16. doi: 10.1016/j.bbmt.2015.07.019. Epub 2015 Jul 26.
3
[The Chinese expert consensus on hematopoietic stem cell transplantation for malignant lymphoma(2018)].《中国恶性淋巴瘤造血干细胞移植专家共识（2018年版）》
Zhonghua Zhong Liu Za Zhi. 2018 Dec 23;40(12):927-934. doi: 10.3760/cma.j.issn.0253-3766.2018.12.011.
4
[Prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation].[异基因造血干细胞移植后白血病复发的预防]
Zhonghua Xue Ye Xue Za Zhi. 2013 Aug;34(8):729-32. doi: 10.3760/cma.j.issn.0253-2727.2013.08.020.
5
[Analysis of Risk Factors and Therapeutic Strategies for Relapse of Leukemia after Allogeneic Hematopoietic Stem Cell Transplantation].异基因造血干细胞移植后白血病复发的危险因素分析及治疗策略
Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2016 Aug;24(4):1137-42. doi: 10.7534/j.issn.1009-2137.2016.04.033.
6
Monitoring mixed lineage leukemia expression may help identify patients with mixed lineage leukemia--rearranged acute leukemia who are at high risk of relapse after allogeneic hematopoietic stem cell transplantation.监测混合谱系白血病的表达可能有助于识别混合谱系白血病重排急性白血病患者，这些患者在异基因造血干细胞移植后有高复发风险。
Biol Blood Marrow Transplant. 2014 Jul;20(7):929-36. doi: 10.1016/j.bbmt.2014.03.008. Epub 2014 Mar 13.
7
Risk assessment of relapse by lineage-specific monitoring of chimerism in children undergoing allogeneic stem cell transplantation for acute lymphoblastic leukemia.通过对接受急性淋巴细胞白血病异基因干细胞移植的儿童进行嵌合体的谱系特异性监测来评估复发风险。
Haematologica. 2016 Jun;101(6):741-6. doi: 10.3324/haematol.2015.135137. Epub 2016 Feb 11.
8
9
[Prevention and treatment of leukemia relapse after allogeneic hematopoietic stem cell transplantation for acute leukemias].[急性白血病异基因造血干细胞移植后白血病复发的防治]
Zhonghua Xue Ye Xue Za Zhi. 2007 Dec;28(12):793-4.
10
Use of tyrosine kinase inhibitors to prevent relapse after allogeneic hematopoietic stem cell transplantation for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia: A position statement of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.酪氨酸激酶抑制剂在费城染色体阳性急性淋巴细胞白血病患者异基因造血干细胞移植后预防复发中的应用：欧洲血液和骨髓移植学会急性白血病工作组的立场声明。
Cancer. 2016 Oct;122(19):2941-51. doi: 10.1002/cncr.30130. Epub 2016 Jun 16.
引用本文的文献
1
Lower Absolute Lymphocyte Count Before Conditioning Predicts High Relapse Risk in Patients After Haploidentical Peripheral Blood Stem Cell Transplantation With Low Dose Anti-Thymocyte Globulin/Post-Transplant Cyclophosphamide for GvHD Prophylaxis.预处理时绝对淋巴细胞计数较低预示着低剂量抗胸腺细胞球蛋白/移植后环磷酰胺预防移植物抗宿主病的单倍体外周血造血干细胞移植后患者复发风险较高。
Cell Transplant. 2022 Jan-Dec;31:9636897221079739. doi: 10.1177/09636897221079739.
本文引用的文献
1
The consensus on the monitoring, treatment, and prevention of leukemia relapse after allogeneic hematopoietic stem cell transplantation in China.中国异基因造血干细胞移植后白血病复发的监测、治疗和预防共识。
Cancer Lett. 2018 Dec 1;438:63-75. doi: 10.1016/j.canlet.2018.08.030. Epub 2018 Sep 11.
2
Everyone has a donor: contribution of the Chinese experience to global practice of haploidentical hematopoietic stem cell transplantation.每个人都有供者：中国经验对全球单倍体造血干细胞移植实践的贡献。
Front Med. 2019 Feb;13(1):45-56. doi: 10.1007/s11684-017-0595-7. Epub 2018 Apr 19.
3
Chinese guidelines for treatment of adult primary immune thrombocytopenia.成人原发性免疫性血小板减少症中国治疗指南。
Int J Hematol. 2018 Jun;107(6):615-623. doi: 10.1007/s12185-018-2445-z. Epub 2018 Apr 4.
4
The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology.中国血液学会关于血液系统疾病异基因造血细胞移植适应证、预处理方案及供者选择的共识。
J Hematol Oncol. 2018 Mar 2;11(1):33. doi: 10.1186/s13045-018-0564-x.
5
Use of haploidentical stem cell transplantation continues to increase: the 2015 European Society for Blood and Marrow Transplant activity survey report.单倍体相合干细胞移植的应用持续增加：2015年欧洲血液和骨髓移植学会活动调查报告。
Bone Marrow Transplant. 2017 Jun;52(6):811-817. doi: 10.1038/bmt.2017.34. Epub 2017 Mar 13.
6
Relapse of AML after hematopoietic stem cell transplantation: methods of monitoring and preventive strategies. A review from the ALWP of the EBMT.造血干细胞移植后急性髓系白血病的复发：监测方法与预防策略。欧洲血液与骨髓移植协会急性白血病工作组的综述
Bone Marrow Transplant. 2016 Nov;51(11):1431-1438. doi: 10.1038/bmt.2016.167. Epub 2016 Jun 13.
7
A prospective, molecular epidemiology study of EGFR mutations in Asian patients with advanced non-small-cell lung cancer of adenocarcinoma histology (PIONEER).一项针对亚洲晚期非小细胞肺癌腺癌组织学患者中表皮生长因子受体突变的前瞻性分子流行病学研究（PIONEER）。
J Thorac Oncol. 2014 Feb;9(2):154-62. doi: 10.1097/JTO.0000000000000033.
8
Proceedings from the National Cancer Institute's Second International Workshop on the Biology, Prevention, and Treatment of Relapse After Hematopoietic Stem Cell Transplantation: part III. Prevention and treatment of relapse after allogeneic transplantation.来自国家癌症研究所第二次造血干细胞移植后复发的生物学、预防和治疗国际研讨会的会议记录：第三部分。异基因移植后复发的预防和治疗。
Biol Blood Marrow Transplant. 2014 Jan;20(1):4-13. doi: 10.1016/j.bbmt.2013.08.012. Epub 2013 Sep 7.
9
NCI First International Workshop on the Biology, Prevention, and Treatment of Relapse after Allogeneic Hematopoietic Stem Cell Transplantation: report from the Committee on Disease-Specific Methods and Strategies for Monitoring Relapse following Allogeneic Stem Cell Transplantation. Part I: Methods, acute leukemias, and myelodysplastic syndromes.NCI 首次异体造血干细胞移植后复发的生物学、预防和治疗国际研讨会：来自异体干细胞移植后复发疾病特异性方法和策略委员会的报告。第一部分：方法、急性白血病和骨髓增生异常综合征。
Biol Blood Marrow Transplant. 2010 Sep;16(9):1187-211. doi: 10.1016/j.bbmt.2010.06.008. Epub 2010 Jun 14.
10
Zotero 插件